|
Studies indicated that mice treated with
Prozac (fluoxetine) early in life grow up to be adults with depression
problems. It is unknown whether or not these results will be the same
in humans; however, researchers are concerned that such antidepressant
drugs might carry risks that don't surface until later in life.
Also, researchers suggest that an immature nervous system responds
very differently to antidepressant drugs than a mature nervous system
does.
It was found that mice injected with Prozac as newborns were more
intimidated by new surroundings, than the mice that weren't injected.
In addition to the risks posed to young children taking Prozac and
other SSRI drugs (selective serotonin reuptake inhibitors), there are
also apprehensions regarding the risks presented to unborn babies.
Some studies have suggested such medications may cause subtle
neurological changes in developing fetuses. In fact, a group of
researchers found that babies exposed to SSRIs in the womb are less
sensitive to pain, have altered sleep patterns and a higher occurrence
of tremors.
Also, research has indicated that chemicals in antidepressant drugs
can cause crucial damage to the developing brain.
New Scientist October 26, 2004 |